,815.2 Million by 2028 at a 6.4% CAGR

$13,815.2 Million by 2028 at a 6.4% CAGR

According to Fortune Business Insights, the global Enzymes Market size is projected to reach USD 13,815.2 Million by 2028, at CAGR of 6.4% during forecast period; Booming Healthcare Sector in the U.S. to Propel Demand in North America

/EIN News/ — Pune, India, May 24, 2022 (GLOBE NEWSWIRE) — The global enzymes market size is projected to reach USD 13,815.2 million by 2028 owing to the increasing applications of the latest technologies for enzyme development, states Fortune Business Insights™ in its report, titled “Enzymes Market, 2020-2028”. The report further states that the global market value was USD 9,008.7 million in 2019 and the market is expected to register a CAGR of 6.4% from 2020 to 2028.

Industry Development:

  • In November 2018, China Pharma Holdings, Inc. introduced Noni Enzyme ARARATO, its new health product in the Chinese pharmaceutical market.

Request a Sample Copy of the Global Enzymes Market:

Report Scope & Segmentation

Report Coverage Details
Forecast Period 2020 to 2028
Forecast Period 2020 to 2028 CAGR 6.4%
2027 Value Projection USD 13815.2 Million
Base Year 2019
Market Size in 2018 USD 9008.7 Million
Historical Data for 2016 to 2018
No. of Pages 126
Segments covered By Type, By Source, Geography
Growth Drivers Plants Segment to Showcase Eminent Growth
Increasing Applications of Latest Technologies to Drive Growth
Expansion Strategies to Help Key Players Meet the Rising Demand

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

Increasing Applications of Latest Technologies to Drive Growth

The advent of the latest technologies is estimated to help manufacturers find unique and effective applications of these biocatalysts in numerous end-user industries. Their extensive utilization is projected to drive the global enzymes market growth during the forecast period. Leading Enterprises operating in the market are aiming at expanding their businesses in order to meet the exceeding demand from end users. In October 2017, BASF SE, a prominent multinational chemical company based in Germany, opened a new production unit in Nanjing Chemical Industrial Park, Nanjing, China. The new plant is aimed to develop biocatalyzed acrylamide for the company.

Plants Segment to Showcase Eminent Growth

We have categorized the market on the basis of type, source, product type, and geography. In terms of type, the market is divided into industrial and specialty enzymes. Based on the source, it is fragmented into plants, animals, and microorganisms. The plants segment is showcasing eminent growth with a market share of 19.3% in 2019.

On the basis of product type, it is bifurcated into protease, lipase, carbohydrates, nuclease & polymerase, and others. Lastly, on the basis of geography, it is segmented into North America, Europe, South America, Asia Pacific, and the Middle East & Africa.

In December 2020, Advanced Enzyme Technologies, a leading developer in India, announced the acquisition of SciTech Specialties, one of the leading specialty products manufacturing enterprises. Under the acquisition agreement, the company will get hold of 51% stakes of the acquired party, securing a total shareholding of 520,408 equity shares. As per the company, the acquisition will help the company expand its business on B2B scale. In addition, the applications owned by SciTech in several verticals including human health, food, and animal nutrition will ensure better delivery of the existing products. The acquisition cost the company a total of INR 316.26 million.

Quick buy – Enzymes Market

COVID-19 Impact

The healthcare industry has been hit hard by the COVID-19 pandemic. Some of the major pharmaceutical companies are embarking on being the first ones to develop a COVID-19 vaccine. Amid pandemic, the demand for such biocatalysts has reduced as companies who were originally responsible for developing novel products are presently focusing on manufacturing sanitizers, masks and other essential products. The market has been adversely affected by such incidents. Analysts at our firm have found that the market registered a decline of 1.0% CAGR in 2020.

Booming Healthcare Sector in the U.S. to Propel Demand in North America

North America is anticipated to lead the global enzymes market share during the forecast period. In 2019, the market value stood at USD 3,584.0 million in this region. Key factors propelling the demand in the region are the booming healthcare sector coupled with industry-leading medical research facilities in the U.S. In addition, the evident presence of prominent organizations developing innovative procedures is estimated to further strengthen the market growth.

The market in Europe is predicted to showcase significant growth. Growing investments for research and development of enzyme-related diagnostics from several countries including Germany are expected to drive the market in the region.

Expansion Strategies to Help Key Players Meet the Rising Demand

Key players operating in the global market are embarking upon market expansion strategies in order to meet the demand for such products from their customers. For instance, in June 2019, Novozymes, a global biotechnology company headquartered in Denmark, announced the expansion of its business in East Africa. Presence in the new location will help the company meet the need for these products in the region.

Ask For Customization


List of Key Players Profiled in the Global Enzymes Market:

• BASF SE (Ludwigshafen, Germany)

• DuPont (Delaware, U.S)

• DSM (Heerlen, Netherlands)

• Novozyme (Bagsværd, Denmark)

• Roche Holding (Basel, Switzerland)

• Codeix (California, U.S.)

• Sanofi (Paris, France)

• Advanced Enzymes (Maharashtra, India)

• Other Prominent Players

Table of Content

  • Introduction

    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics

    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
  • Overview of Clinical Trials – Key Candidates, Key Companies
  • Regulatory Scenario
  • Impact of Covid-19 on the Market
  • Key Developments, Mergers, Acquisitions, etc.
  • New Product Launches
  • Global Enzymes Market Analysis, Insights and Forecast, 2016-2027

    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
    • Industrial Enzymes
    • Specialty Enzymes
    • Market Analysis, Insights and Forecast – By Source
    • Plants
    • Animals
    • Microorganisms
    • Market Analysis, Insights and Forecast – By Product Type
    • Protease
    • Lipase
    • Carbohydrates
    • Nuclease & Polymerase
    • Others
    • Market Analysis, Insights and Forecast – By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

ToC Continue…!

Have Any Query? Ask Our Experts:


About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –
Mahalunge Road, Baner, Pune-411045,
Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]

Primary Logo

Article originally published at https://www.einpresswire.com/article/573764992/enzymes-market-13-815-2-million-by-2028-at-a-6-4-cagr

Books - Reality Syndicate Viewers originally published at Books - Reality Syndicate Viewers

Kindle Vella Launch Date Announced? | Self Publishing News (June 21, 2021) Previous post Kindle Vella Launch Date Announced? | Self Publishing News (June 21, 2021)
Chilean Rodeo Kicks in New OTT Provider Next post Chilean Rodeo Kicks in New OTT Provider